1,419 items re-evaluated in 2007

Published: 2008-01-14 06:59:00

Updated: 2008-01-14 06:59:00

The Korea Food and Drug Administration announced that a total of 1,419 items from 13 therapeutic categories, including antineoplastic agents, miscellaneous agents for treatment and diagnostics and chemotherapeutics, were re-evaluated last year.

It added that these drugs were re-evaluated using...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK